The ACBRD is collaborating with an international group to research the impact of open-source artificial pancreas systems
Category: Technologies
Predictors of recurrent severe hypoglycemia in adults type 1 diabetes
The latest in diabetes technologies and treatments
Highlights from the ATTD and a summary of the research presented by the ACBRD
By Jasmine Schipp and Shaira Baptista
A new questionnaire examines satisfaction with glucose monitoring experience
ACBRD develops and validates the novel “Glucose Monitoring Experiences Questionnaire (GME-Q)”, for use among adults with type 1 diabetes.
By Dr Elizabeth Holmes-Truscott
Satisfaction with insulin delivery and glucose monitoring technologies in adults with long-standing type 1 diabetes and recurrent severe hypoglycaemia
Secondary analysis of the HypoCOMPaSS trial highlights greater satisfaction with insulin pump than multiple daily injections
What do adults with type 2 diabetes want from the ‘perfect’ app? Results from the second Diabetes MILES—Australia (MILES-2) study
Our recently published study shows that adults with type 2 diabetes want both practical and psychological support from diabetes self-management apps
A focus on language, stigma and communication at the #ADA2019
Highlights of the ACBRD’s contributions to the American Diabetes Association conference 2019
What are people discussing about #OpenAPS on Twitter?
A study by US researchers examines Twitter conversations about a do-it-yourself (DIY) open source artificial pancreas systems (OpenAPS)
Closed-loop technology: “It is definitely a game changer” for people with type 1 diabetes
An interview study from the ACBRD details experiences with a brief overnight trial of a hybrid closed-loop system